These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 33977455

  • 1. High-Throughput Screening Assays for Dengue Antiviral Drug Development.
    Jabanathan SG, Xuan LZ, Ramanathan B.
    Methods Mol Biol; 2021; 2296():279-302. PubMed ID: 33977455
    [Abstract] [Full Text] [Related]

  • 2. Antiviral activity of four types of bioflavonoid against dengue virus type-2.
    Zandi K, Teoh BT, Sam SS, Wong PF, Mustafa MR, Abubakar S.
    Virol J; 2011 Dec 28; 8():560. PubMed ID: 22201648
    [Abstract] [Full Text] [Related]

  • 3. Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry.
    Kuo YT, Liu CH, Li JW, Lin CJ, Jassey A, Wu HN, Perng GC, Yen MH, Lin LT.
    Sci Rep; 2020 Oct 02; 10(1):16378. PubMed ID: 33009425
    [Abstract] [Full Text] [Related]

  • 4. Nucleoside Analogs with Selective Antiviral Activity against Dengue Fever and Japanese Encephalitis Viruses.
    Zandi K, Bassit L, Amblard F, Cox BD, Hassandarvish P, Moghaddam E, Yueh A, Libanio Rodrigues GO, Passos I, Costa VV, AbuBakar S, Zhou L, Kohler J, Teixeira MM, Schinazi RF.
    Antimicrob Agents Chemother; 2019 Jul 02; 63(7):. PubMed ID: 31061163
    [Abstract] [Full Text] [Related]

  • 5. Betulinic acid exhibits antiviral effects against dengue virus infection.
    Loe MWC, Hao E, Chen M, Li C, Lee RCH, Zhu IXY, Teo ZY, Chin WX, Hou X, Deng J, Chu JJH.
    Antiviral Res; 2020 Dec 02; 184():104954. PubMed ID: 33080251
    [Abstract] [Full Text] [Related]

  • 6. A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells.
    Beesetti H, Tyagi P, Medapi B, Krishna VS, Sriram D, Khanna N, Swaminathan S.
    Antivir Ther; 2018 Dec 02; 23(5):385-394. PubMed ID: 29583121
    [Abstract] [Full Text] [Related]

  • 7. Tomatidine, a novel antiviral compound towards dengue virus.
    Diosa-Toro M, Troost B, van de Pol D, Heberle AM, Urcuqui-Inchima S, Thedieck K, Smit JM.
    Antiviral Res; 2019 Jan 02; 161():90-99. PubMed ID: 30468746
    [Abstract] [Full Text] [Related]

  • 8. Extract of Scutellaria baicalensis inhibits dengue virus replication.
    Zandi K, Lim TH, Rahim NA, Shu MH, Teoh BT, Sam SS, Danlami MB, Tan KK, Abubakar S.
    BMC Complement Altern Med; 2013 Apr 29; 13():91. PubMed ID: 23627436
    [Abstract] [Full Text] [Related]

  • 9. Novel antiviral activity of baicalein against dengue virus.
    Zandi K, Teoh BT, Sam SS, Wong PF, Mustafa MR, Abubakar S.
    BMC Complement Altern Med; 2012 Nov 09; 12():214. PubMed ID: 23140177
    [Abstract] [Full Text] [Related]

  • 10. A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses.
    Yang CC, Hu HS, Lin HM, Wu PS, Wu RH, Tian JN, Wu SH, Tsou LK, Song JS, Chen HW, Chern JH, Chen CT, Yueh A.
    Antiviral Res; 2019 Dec 09; 172():104636. PubMed ID: 31654671
    [Abstract] [Full Text] [Related]

  • 11. Antiviral activity of silymarin and baicalein against dengue virus.
    Low ZX, OuYong BM, Hassandarvish P, Poh CL, Ramanathan B.
    Sci Rep; 2021 Oct 27; 11(1):21221. PubMed ID: 34707245
    [Abstract] [Full Text] [Related]

  • 12. Drug repurposing of quinine as antiviral against dengue virus infection.
    Malakar S, Sreelatha L, Dechtawewat T, Noisakran S, Yenchitsomanus PT, Chu JJH, Limjindaporn T.
    Virus Res; 2018 Aug 15; 255():171-178. PubMed ID: 30055216
    [Abstract] [Full Text] [Related]

  • 13. Anti-dengue virus serotype 2 activity and mode of action of a novel peptide.
    Chew MF, Tham HW, Rajik M, Sharifah SH.
    J Appl Microbiol; 2015 Oct 15; 119(4):1170-80. PubMed ID: 26248692
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of geraniin on dengue virus type-2 infected BALB/c mice.
    Abdul Ahmad SA, Palanisamy UD, Khoo JJ, Dhanoa A, Syed Hassan S.
    Virol J; 2019 Feb 27; 16(1):26. PubMed ID: 30813954
    [Abstract] [Full Text] [Related]

  • 15. Exploring the in vitro potential of celecoxib derivative AR-12 as an effective antiviral compound against four dengue virus serotypes.
    Hassandarvish P, Oo A, Jokar A, Zukiwski A, Proniuk S, Abu Bakar S, Zandi K.
    J Antimicrob Chemother; 2017 Sep 01; 72(9):2438-2442. PubMed ID: 28666323
    [Abstract] [Full Text] [Related]

  • 16. Identification of a Direct-Acting Antiviral Agent Targeting RNA Helicase via a Graphene Oxide Nanobiosensor.
    Kim J, Park SJ, Park J, Shin H, Jang YS, Woo JS, Min DH.
    ACS Appl Mater Interfaces; 2021 Jun 09; 13(22):25715-25726. PubMed ID: 34036784
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of dengue virus through suppression of host pyrimidine biosynthesis.
    Wang QY, Bushell S, Qing M, Xu HY, Bonavia A, Nunes S, Zhou J, Poh MK, Florez de Sessions P, Niyomrattanakit P, Dong H, Hoffmaster K, Goh A, Nilar S, Schul W, Jones S, Kramer L, Compton T, Shi PY.
    J Virol; 2011 Jul 09; 85(13):6548-56. PubMed ID: 21507975
    [Abstract] [Full Text] [Related]

  • 18. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
    Low JS, Wu KX, Chen KC, Ng MM, Chu JJ.
    Antivir Ther; 2011 Jul 09; 16(8):1203-18. PubMed ID: 22155902
    [Abstract] [Full Text] [Related]

  • 19. Development of specific dengue virus 2'-O- and N7-methyltransferase assays for antiviral drug screening.
    Barral K, Sallamand C, Petzold C, Coutard B, Collet A, Thillier Y, Zimmermann J, Vasseur JJ, Canard B, Rohayem J, Debart F, Decroly E.
    Antiviral Res; 2013 Sep 09; 99(3):292-300. PubMed ID: 23769894
    [Abstract] [Full Text] [Related]

  • 20. Antiviral Evaluation of UV-4B and Interferon-Alpha Combination Regimens against Dengue Virus.
    Franco EJ, Pires de Mello CP, Brown AN.
    Viruses; 2021 Apr 27; 13(5):. PubMed ID: 33925551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.